Physician

Ahmad Firas Sabbagh, MD

According to 2025 Medicare claims, Ahmad Sabbagh, MD (NPI: 1528180825) practices endocrinology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is NORTHERN OHIO MEDICAL SPECIALISTS LLC (NPI: 1225085855; TIN: 341933718) and primary practice location at 44870-5391. Sabbagh is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Sabbagh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 709 traditional Medicare patients, billed 2,699 HCPCS/CPT codes, and received $122,955 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,914 prescription claims across 691 beneficiaries totaling $2,461,980 in drug costs, led by Ozempic (Semaglutide). DME data shows 274 claims. Open Payments data shows 84 records totaling $1,342. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,515,190 to $2,461,980. For DME billing, reported payments moved sharply higher in recent years, from $19,104 to $72,618.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,079	3,539	$187,375
2016	1,079	3,263	$167,517
2017	903	2,398	$121,518
2018	614	2,257	$118,691
2019	767	2,754	$145,299
2020	756	2,879	$143,096
2021	708	2,914	$144,038
2022	710	2,326	$133,475
2023	704	2,009	$129,460
2024	709	2,699	$122,955

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	572	3,992	$1,515,190
2016	623	4,451	$1,861,660
2017	614	3,500	$1,447,970
2018	349	1,828	$705,522
2019	397	2,736	$1,369,630
2020	441	3,285	$1,721,561
2021	500	3,664	$1,917,578
2022	560	4,097	$2,309,240
2023	618	4,400	$2,925,308
2024	691	4,914	$2,461,980

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	329	752	$35,999
2016	389	827	$38,729
2017	304	701	$45,895
2018	130	345	$13,752
2019	105	301	$14,419
2020	85	300	$24,717
2021	71	274	$37,226
2022	71	291	$44,858
2023	78	325	$43,583
2024	93	274	$71,306

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	206	211	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	335	562	$80
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	137	322	$58
83036	Hemoglobin a1c level	153	311	$9
82962	Blood glucose (sugar) test performed by hand-held instrument	148	285	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	194	10,804	$347,412
Jardiance	Empagliflozin	239	14,129	$273,111
Trulicity	Dulaglutide	129	6,878	$227,207
Januvia	Sitagliptin Phosphate	170	11,194	$196,225
Humulin R U-500 Kwikpen	Insulin Regular, Human	65	2,416	$129,201

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	36	164	$66,865
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	12	12	$2,393
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	33	73	$1,986
A4259	Lancets, per box of 100	N	12	25	$62

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	84	$1,342	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Firas Sabbagh, MD?

Tedicare shows public-source Medicare data for Ahmad Firas Sabbagh, MD (NPI 1528180825), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Firas Sabbagh, MD have ACO affiliation data?

Ahmad Firas Sabbagh, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Ahmad Firas Sabbagh, MD?

Ahmad Firas Sabbagh, MD is linked to NORTHERN OHIO MEDICAL SPECIALISTS LLC (billing NPI 1225085855) in the available physician profile data.

Does Ahmad Firas Sabbagh, MD have Open Payments data?

Ahmad Firas Sabbagh, MD has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.